Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Samelisant
DRUG
2 trials
Sponsors
Suven Life Sciences Limited
Conditions
Narcolepsy
Phase 3
A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)
Recruiting
NCT07540364
Suven Life Sciences Limited
Narcolepsy
Start: 2026-09-01
End: 2027-12-19
Target: 240
Updated: 2026-09-03
Unknown Phase
Expanded Access to SUVN-G3031 (Samelisant) for the Treatment of Subjects With Narcolepsy
NCT05530447
Suven Life Sciences Limited
Narcolepsy
Updated: 2022-09-23